Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-FMPP PET MPI for CAD Detection
NCT04596527Phase 1Unknown
- Sponsor
- Peking Union Medical College Hospital
- Start
- Sep 2020
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of 18F-FMPP in coronary artery disease (CAD), sponsored by Peking Union Medical College Hospital. Primary endpoint: Diagnostic performance of 18F-FMPP PET MPI in the detection of CAD at 2 years. Status: unknown.
02
Drugs
18F-FMPP
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT04596527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596527.